注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Brainstorm Cell Therapeutics Inc是一家生物技术公司。该公司专注于开发和商业化用于治疗神经退行性疾病的自体细胞疗法,包括肌萎缩侧索硬化症(ALS,也称为 Lou Gehrig 病)、进行性多发性硬化症(PMS)、阿尔茨海默病(AD)等神经退行性疾病。NurOwn是其细胞治疗平台,该平台利用细胞培养方法诱导自体骨髓间充质干细胞 (MSCs) 分泌高水平的神经营养因子 (NTF),调节神经炎症和神经退行性疾病过程,促进神经元存活并改善神经功能。NurOwn已完成其III期ALS和II期PMS临床试验。其全资子公司BrainStorm Cell Therapeutics Ltd拥有将其NurOwn技术商业化的权利。其他子公司包括Advanced Cell Therapies Ltd和另外两家。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Jacob Ahron Frenkel | 78 | 2007 | Independent Chairman of the Board |
Andrew Hill Card | 73 | 2011 | Member of Business Advisory Board |
Rasheda Ali | - | 2007 | Member of Business Advisory Board |
Irit Arbel | 63 | 2004 | Co-Founder & Independent Vice Chair of the Board |
Jerold Chun | - | 2018 | Chairman of Scientific Advisory Board |
Nir Naor | 49 | 2023 | Independent Director |
Stanley H. Appel | 90 | - | Member of Scientific Advisory Board |
Menghisteab Bairu | 62 | 2021 | Independent Director |
Amit Bar-Or | - | - | Member of Scientific Advisory Board |
Ralph Z. Kern | 65 | 2017 | Member of Scientific Advisory Board |
Anthony J. Polverino | 60 | 2018 | Independent Director |
Uri Yablonka | 47 | 2014 | Executive VP, Chief Business Officer, Secretary & Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核